教育经历 2009.09—2013.07 河南师范大学生物技术专业本科生 2013.09—2018.07 复旦大学生物化学与分子生物学专业博士研究生 工作经历 2018.07—2021.08 复旦大学基础医学院博士后 2021.09—至今 复旦大学基础医学院青年副研究员

基于蛋白质构效关系，设计新型生物技术新药 肿瘤免疫治疗 凝血系统在肿瘤发生发展中的作用机制研究

Wu M., Xia T., Li Y., Wang T., Yang S., Yu J., Liang Q., Shen T.*, Yu M.*, Zhao B.*Design and fabrication of r-hirudin loaded dissolving microneedle patch for minimally invasive and long-term treatment of thromboembolic disease. Asian Journal of Pharmaceutical Sciences, doi: 10.1016/j.ajps.2022.02.005, 2022 Zhao B.*#, Wu M.#, Hu Z.#, Wang T., Yu J., Ma Y., Wang Q., Zhang Y., Chen D., Li T., Li Y., Yu M*, Wang H.*, Mo W.* A novel oncotherapy strategy, direct thrombin inhibitors suppress progression, dissemination and spontaneous metastasis in non-small cell lung cancer. British Journal of Pharmacology, doi: 10.1111/bph.15384, .2021 Zhao B., Wu M., Hu Z., Ma Y., Wang Q., Zhang Y., Li Y., Yu M., Wang H.*, Mo W.* Thrombin is a therapeutic target for non-small cell lung cancer to inhibit vasculogenic mimicry formation; Signal Transduction and Targeted Therapy, 5(1): 1556-1567, 2020 Zhao B., Zhang Y., Huang Y., Yu J., Li Y., Wang Q., Ma Y., Song H., Yu M., Mo W.* A novel hirudin derivative inhibiting thrombin without bleeding for subcutaneous Injection. Thrombosis and Haemostasis, 117(1): 44-56, 2017.